OBJECTIVE: IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS: Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS: IGFBP-1 levels more strongly correlated with M (R = 0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS: These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.
OBJECTIVE:IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS: Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS:IGFBP-1 levels more strongly correlated with M (R = 0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS: These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.
Authors: James L Devin; Michelle M Hill; Marina Mourtzakis; Joe Quadrilatero; David G Jenkins; Tina L Skinner Journal: J Physiol Date: 2019-03-20 Impact factor: 5.182
Authors: Amir Aziz; Natalie J Haywood; Paul A Cordell; Jess Smith; Nadira Y Yuldasheva; Anshuman Sengupta; Noman Ali; Ben N Mercer; Romana S Mughal; Kirsten Riches; Richard M Cubbon; Karen E Porter; Mark T Kearney; Stephen B Wheatcroft Journal: Endocrinology Date: 2018-02-01 Impact factor: 4.736
Authors: Abigail C Lay; Lorna J Hale; Holly Stowell-Connolly; Robert J P Pope; Viji Nair; Wenjun Ju; Eva Marquez; Ruth Rollason; Jenny A Hurcombe; Bryony Hayes; Timothy Roberts; Lawrence Gillam; Jonathan Allington; Robert G Nelson; Matthias Kretzler; Jeff M P Holly; Claire M Perks; Craig A McArdle; Gavin I Welsh; Richard J M Coward Journal: Diabetologia Date: 2021-03-24 Impact factor: 10.460
Authors: Adil Rajwani; Vivienne Ezzat; Jessica Smith; Nadira Y Yuldasheva; Edward R Duncan; Matthew Gage; Richard M Cubbon; Matthew B Kahn; Helen Imrie; Afroze Abbas; Hema Viswambharan; Amir Aziz; Piruthivi Sukumar; Antonio Vidal-Puig; Jaswinder K Sethi; Shouhong Xuan; Ajay M Shah; Peter J Grant; Karen E Porter; Mark T Kearney; Stephen B Wheatcroft Journal: Diabetes Date: 2012-02-22 Impact factor: 9.461